Hims & Hers Health, Inc.
Hims & Hers Health Appoints Deb Autor to Board of Directors
Summary
Hims & Hers Health, Inc. announced on November 15, 2024, the appointment of Deb Autor to its Board of Directors, expanding the Board from nine to ten members. Deb Autor, aged 57, has been appointed to serve until the Company's 2025 annual meeting of stockholders. In addition to her role as a director, Autor has entered into a consulting agreement with the Company for a one-year period, under which she will receive a consulting fee of $100,000. She has also been appointed to the Risk Committee of the Board. There are no arrangements or understandings between Autor and any other persons that would require disclosure.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement